Bacteriocin production: A relatively unharnessed probiotic trait?

F1000Research

Volumn 5, Issue , 2016, Pages

  Hegarty, James W ^a,b   Guinane, Caitriona M ^a   Ross, R Paul ^a,c   Hill, Colin ^b,c   Cotter, Paul D ^a,c  

^a TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Bacteriocin; Gut health; Microbiota; Probiotic

Indexed keywords

EID: 85022194226     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.9615.1     Document Type: Review

References (74)

1. Cotter PD Hill C Ross RP : Bacteriocins: developing innate immunity for food. Nat Rev Microbiol. 2005;3(10):777-88. 16205711 10.1038/nrmicro1273
2. Gillor O Etzion A Riley MA : The dual role of bacteriocins as anti- and probiotics. Appl Microbiol Biotechnol. 2008;81(4):591-606. 18853155 10.1007/s00253-008-1726-5 2670069
3. Guinane CM Piper C Draper LA : Impact of Environmental Factors on Bacteriocin Promoter Activity in Gut-Derived Lactobacillus salivarius. Appl Environ Microbiol. 2015;81(22):7851-9. 26341205 10.1128/AEM.02339-15 4616941
4. Fernandez B Le Lay C Jean J : Growth, acid production and bacteriocin production by probiotic candidates under simulated colonic conditions. J Appl Microbiol. 2013;114(3):877-85. 23167818 10.1111/jam.12081
5. Turgis M Vu KD Millette M : Influence of Environmental Factors on Bacteriocin Production by Human Isolates of Lactococcus lactis MM19 and Pediococcus acidilactici MM33. Probiotics Antimicrob Proteins. 2016;8(1):53-9. 26686688 10.1007/s12602-015-9204-8
6. Cotter PD Ross RP Hill C : Bacteriocins - a viable alternative to antibiotics? Nat Rev Microbiol. 2013;11(2):95-105. 23268227 10.1038/nrmicro2937
7. Dobson A Cotter PD Ross RP : Bacteriocin production: a probiotic trait? Appl Environ Microbiol. 2012;78(1):1-6. 22038602 10.1128/AEM.05576-11 3255625
8. Walsh MC Gardiner GE Hart OM : Predominance of a bacteriocin-producing Lactobacillus salivarius component of a five-strain probiotic in the porcine ileum and effects on host immune phenotype. FEMS Microbiol Ecol. 2008;64(2):317-27. 18373687 10.1111/j.1574-6941.2008.00454.x
9. Corr SC Li Y Riedel CU : Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci U S A. 2007;104(18):7617-21. 17456596 10.1073/pnas.0700440104 1863472
10. van Hemert S Meijerink M Molenaar D : Identification of Lactobacillus plantarum genes modulating the cytokine response of human peripheral blood mononuclear cells. BMC Microbiol. 2010;10:293. 21080958 10.1186/1471-2180-10-293 3000848
11. Drider D Bendali F Naghmouchi K : Bacteriocins: Not Only Antibacterial Agents. Probiotics Antimicrob Proteins. 2016;1-6. 27481236 10.1007/s12602-016-9223-0
12. Hill C Guarner F Reid G : Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-14. 24912386 10.1038/nrgastro.2014.66
13. Martinez FA Balciunas EM Converti A : Bacteriocin production by Bifidobacterium spp. A review. Biotechnol Adv. 2013;31(4):482-8. 23384878 10.1016/j.biotechadv.2013.01.010
14. Zheng J Gänzle MG Lin XB : Diversity and dynamics of bacteriocins from human microbiome. Environ Microbiol. 2015;17(6):2133-43. 25346017 10.1111/1462-2920.12662
15. Walsh CJ Guinane CM Hill C : In silico identification of bacteriocin gene clusters in the gastrointestinal tract, based on the Human Microbiome Project's reference genome database. BMC Microbiol. 2015;15:183. 26377179 10.1186/s12866-015-0515-4 4573289
16. Guarner F Khan AG Garisch J : World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol. 2012;46(6):468-81. 22688142 10.1097/MCG.0b013e3182549092
17. Sanders ME Guarner F Guerrant R : An update on the use and investigation of probiotics in health and disease. Gut. 2013;62(5):787-796. 23474420 10.1136/gutjnl-2012-302504 4351195
18. Meijerink M van Hemert S Taverne N : Identification of genetic loci in Lactobacillus plantarum that modulate the immune response of dendritic cells using comparative genome hybridization. PLoS One. 2010;5(5):e10632. 20498715 10.1371/journal.pone.0010632 2869364
19. Gotteland M Andrews M Toledo M : Modulation of Helicobacter pylori colonization with cranberry juice and Lactobacillus johnsonii La1 in children. Nutrition. 2008;24(5):421-6. 18343637 10.1016/j.nut.2008.01.007
20. Stern NJ Svetoch EA Eruslanov BV : Isolation of a Lactobacillus salivarius strain and purification of its bacteriocin, which is inhibitory to Campylobacter jejuni in the chicken gastrointestinal system. Antimicrob Agents Chemother. 2006;50(9):3111-6. 16940109 10.1128/AAC.00259-06 1563535
21. Svetoch EA Eruslanov BV Levchuk VP : Isolation of Lactobacillus salivarius 1077 (NRRL B-50053) and characterization of its bacteriocin, including the antimicrobial activity spectrum. Appl Environ Microbiol. 2011;77(8):2749-54. 21378051 10.1128/AEM.02481-10 3126352
22. O'Shea EF Gardiner GE O'Connor PM : Characterization of enterocin- and salivaricin-producing lactic acid bacteria from the mammalian gastrointestinal tract. FEMS Microbiol Lett. 2009;291(1):24-34. 19076236 10.1111/j.1574-6968.2008.01427.x
23. O'Shea EF O'Connor PM Raftis EJ : Production of multiple bacteriocins from a single locus by gastrointestinal strains of Lactobacillus salivarius. J Bacteriol. 2011;193(24):6973-82. 21984788 10.1128/JB.06221-11 3232826
24. O'Shea EF O'Connor PM O'Sullivan O : Bactofencin A, a new type of cationic bacteriocin with unusual immunity. MBio. 2013;4(6):e00498-13. 24169573 10.1128/mBio.00498-13 3809560
25. Guinane CM Lawton EM O'Connor PM : The bacteriocin bactofencin A subtly modulates gut microbial populations. Anaerobe. 2016;40:41-9. 27154638 10.1016/j.anaerobe.2016.05.001
26. Flynn S van Sinderen D Thornton GM : Characterization of the genetic locus responsible for the production of ABP-118, a novel bacteriocin produced by the probiotic bacterium Lactobacillus salivarius subsp. salivarius UCC118. Microbiology. 2002;148(Pt 4):973-84. 11932444 10.1099/00221287-148-4-973
27. Dunne C Murphy L Flynn S : Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie Van Leeuwenhoek. 1999;76(1-4):279-92. 10532384 10.1023/A:1002065931997
28. Murphy EF Cotter PD Hogan A : Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut. 2013;62(2):220-6. 22345653 10.1136/gutjnl-2011-300705
29. van Pijkeren JP Canchaya C Ryan KA : Comparative and functional analysis of sortase-dependent proteins in the predicted secretome of Lactobacillus salivarius UCC118. Appl Environ Microbiol. 2006;72(6):4143-53. 16751526 10.1128/AEM.03023-05 1489637
30. O'Callaghan J Buttó LF MacSharry J : Influence of adhesion and bacteriocin production by Lactobacillus salivarius on the intestinal epithelial cell transcriptional response. Appl Environ Microbiol. 2012;78(15):5196-203. 22610429 10.1128/AEM.00507-12 3416450
31. Shah NP : Functional cultures and health benefits. Int Dairy J. 2007;17(11):1262-1277. 10.1016/j.idairyj.2007.01.014
32. Bull M Plummer S Marchesi J : The life history of Lactobacillus acidophilus as a probiotic: a tale of revisionary taxonomy, misidentification and commercial success. FEMS Microbiol Lett. 2013;349(2):77-87. 24152174 10.1111/1574-6968.12293
33. Sanders ME Klaenhammer TR : Invited review: the scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic. J Dairy Sci. 2001;84(2):319-31. 11233016 10.3168/jds.S0022-0302(01)74481-5
34. Tabasco R García-Cayuela T Peláez C : Lactobacillus acidophilus La-5 increases lactacin B production when it senses live target bacteria. Int J Food Microbiol. 2009;132(2-3):109-16. 19411126 10.1016/j.ijfoodmicro.2009.04.004
35. Barefoot SF Klaenhammer TR : Purification and characterization of the Lactobacillus acidophilus bacteriocin lactacin B. Antimicrob Agents Chemother. 1984;26(3):328-34. 6439113 10.1128/AAC.26.3.328 176163
36. Aas JA Paster BJ Stokes LN : Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005;43(11):5721-32. 16272510 10.1128/JCM.43.11.5721-5732.2005 1287824
37. Pearce C Bowden GH Evans M : Identification of pioneer viridans streptococci in the oral cavity of human neonates. J Med Microbiol. 1995;42(1):67-72. 7739028 10.1099/00222615-42-1-67
38. Burton JP Chilcott CN Tagg JR : The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics. Oral Dis. 2005;11(Suppl 1):29-31. 15752094 10.1111/j.1601-0825.2005.01084.x
39. Burton JP Wescombe PA Moore CJ : Safety assessment of the oral cavity probiotic Streptococcus salivarius K12. Appl Environ Microbiol. 2006;72(4):3050-3. 16598017 10.1128/AEM.72.4.3050-3053.2006 1449041
40. Wescombe PA Hale JD Heng NC : Developing oral probiotics from Streptococcus salivarius. Future Microbiol. 2012;7(12):1355-71. 23231486 10.2217/fmb.12.113
41. Patras KA Wescombe PA Rösler B : Streptococcus salivarius K12 Limits Group B Streptococcus Vaginal Colonization. Infect Immun. 2015;83(9):3438-44. 26077762 10.1128/IAI.00409-15 4534663
42. Heng NC Haji-Ishak NS Kalyan A : Genome sequence of the bacteriocin-producing oral probiotic Streptococcus salivarius strain M18. J Bacteriol. 2011;193(22):6402-3. 22038965 10.1128/JB.06001-11 3209194
43. Burton JP Drummond BK Chilcott CN : Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebo-controlled trial. J Med Microbiol. 2013;62(Pt 6):875-84. 23449874 10.1099/jmm.0.056663-0
44. Burton JP Wescombe PA Macklaim JM : Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics. PLoS One. 2013;8(6):e65991. 23785463 10.1371/journal.pone.0065991 3681767
45. Wescombe PA Upton M Renault P : Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius. Microbiology. 2011;157(Pt 5):1290-9. 21310787 10.1099/mic.0.044719-0
46. Walker GV Heng NC Carne A : Salivaricin E and abundant dextranase activity may contribute to the anti-cariogenic potential of the probiotic candidate Streptococcus salivarius JH. Microbiology. 2016;162(3):476-86. 26744310 10.1099/mic.0.000237
47. Kommineni S Bretl DJ Lam V : Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract. Nature. 2015;526(7575):719-22. 26479034 10.1038/nature15524 4978352
48. Janek D Zipperer A Kulik A : High Frequency and Diversity of Antimicrobial Activities Produced by Nasal Staphylococcus Strains against Bacterial Competitors. PLoS Pathog. 2016;12(8):e1005812. 27490492 10.1371/journal.ppat.1005812 4973975
49. Ley RE Bäckhed F Turnbaugh P : Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102(31):11070-5. 16033867 10.1073/pnas.0504978102 1176910
50. Turnbaugh PJ Ley RE Mahowald MA : An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027-31. 17183312 10.1038/nature05414
51. Schwiertz A Taras D Schäfer K : Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 2010;18(1):190-5. 19498350 10.1038/oby.2009.167
52. Turnbaugh PJ Bäckhed F Fulton L : Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008;3(4):213-23. 18407065 10.1016/j.chom.2008.02.015 3687783
53. Le Chatelier E Nielsen T Qin J : Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500(7464):541-6. 23985870 10.1038/nature12506
54. Everard A Belzer C Geurts L : Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013;110(22):9066-71. 23671105 10.1073/pnas.1219451110 3670398
55. Larsen N Vogensen FK van den Berg FW : Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 2010;5(2):e9085. 20140211 10.1371/journal.pone.0009085 2816710
56. Qin J Li Y Cai Z : A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55-60. 23023125 10.1038/nature11450
57. Karlsson FH Tremaroli V Nookaew I : Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99-103. 23719380 10.1038/nature12198
58. Fei N Zhao L : An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J. 2013;7(4):880-4. 23235292 10.1038/ismej.2012.153 3603399
59. Woting A Pfeiffer N Loh G : Clostridium ramosum promotes high-fat diet-induced obesity in gnotobiotic mouse models. MBio. 2014;5(5):e01530-14. 25271283 10.1128/mBio.01530-14 4196224
60. Kaur S Kaur S : Bacteriocins as Potential Anticancer Agents. Front Pharmacol. 2015;6:272. 26617524 10.3389/fphar.2015.00272 4639596
61. Joo NE Ritchie K Kamarajan P : Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1. Cancer Med. 2012;1(3):295-305. 23342279 10.1002/cam4.35 3544465
62. Allen-Vercoe E Strauss J Chadee K : Fusobacterium nucleatum: an emerging gut pathogen? Gut Microbes. 2011;2(5):294-8. 22067936 10.4161/gmic.2.5.18603
63. Castellarin M Warren RL Freeman JD : Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22(2):299-306. 22009989 10.1101/gr.126516.111 3266037
64. Kostic AD Chun E Robertson L : Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207-15. 23954159 10.1016/j.chom.2013.07.007 3772512
65. Strauss J Kaplan GG Beck PL : Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis. 2011;17(9):1971-8. 21830275 10.1002/ibd.21606
66. Swidsinski A Dörffel Y Loening-Baucke V : Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut. 2011;60(1):34-40. 19926616 10.1136/gut.2009.191320
67. Rubinstein MR Wang X Liu W : Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14(2):195-206. 23954158 10.1016/j.chom.2013.07.012 3770529
68. Gur C Ibrahim Y Isaacson B : Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity. 2015;42(2):344-55. 25680274 10.1016/j.immuni.2015.01.010 4361732
69. O'Shea EF Gardiner GE O'Connor PM : Characterization of enterocin- and salivaricin-producing lactic acid bacteria from the mammalian gastrointestinal tract. FEMS Microbiol Lett. 2009;291(1):24-34. 19076236 10.1111/j.1574-6968.2008.01427.x
70. Rea MC Sit CS Clayton E : Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc Natl Acad Sci U S A. 2010;107(20):9352-7. 20435915 10.1073/pnas.0913554107 2889069
71. Birri DJ Brede DA Nes IF : Salivaricin D, a novel intrinsically trypsin-resistant lantibiotic from Streptococcus salivarius 5M6c isolated from a healthy infant. Appl Environ Microbiol. 2012;78(2):402-10. 22101034 10.1128/AEM.06588-11 3255740
72. Dao MC Everard A Aron-Wisnewsky J : Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut. 2016;65(3):426-36. 26100928 10.1136/gutjnl-2014-308778
73. Miquel S Leclerc M Martin R : Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii. MBio. 2015;6(2): pii: e00300-15. 25900655 10.1128/mBio.00300-15 4453580
74. Hatziioanou D Mayer MJ Duncan SH : A representative of the dominant human colonic Firmicutes, Roseburia faecis M72/1, forms a novel bacteriocin-like substance. Anaerobe. 2013;23(7):5-8. 23916720 10.1016/j.anaerobe.2013.07.006